close

Syncom Formulations (India) Ltd

Know more

BSE : 524470

NSE : SYNCOMF

Sector :Health care

ISIN Code : INE312C01025

NSE

5.00
-0.40 (-7.41%)

00:00 AM,28th Mar 2023
Open
5.45
High
5.60
Low
4.55

BSE

4.99
-0.40 (-7.42%)

00:00 AM,28th Mar 2023
Open
5.42
High
5.60
Low
4.55

Syncom Formulations (India) Ltd

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y

Statistics Overview

M.cap

469.06

Volume

1296009

52-Week High

13.00

52-Week Low

4.55

EPS-TTM

4.99

About Syncom Formulations (India) Ltd.

Incorporated as a private limited company in 1988 Syncom Formulations (India) was converted into a public limited company in Jun.'92. The company set up a manufacturing facility at Palghar Thane to produce pharmaceutical formulations. Commercial production commenced in Apr.'89. Promoters are Kedarmal Bankda Vijay Kumar Bankda and Ajay Kumar Bankda.In addition to pharmaceutical formulations in the

...Read more

F & O Quote

No Data Found

Share Price Returns

Stock Strength

Financials

  • Graph
  • Table

Bulk/ Block

  • ALL
  • NSE
  • BSE
  • ALL
  • BUY
  • SELL

No record

DateClient NameExchangeTransactionQuantityPrice

Peer Group Comparison

  • Graph
  • Table
DatePrice (X)

Shareholding Pattern

  • Graph
  • Table

Corporate Action

No record

Announcement DatePurposeFromToRemarks

Price History

Search for Price History

DateOpenHighLowCloseSharesTrades

Load more

Company Info

Company Information

Chairman & Wholetime Director : Kedarmal Bankda

Managing Director : Vijay Shankarlal Bankda

Independent Director : Vinod Kumar Kabra

Independent Director : Krishna Das Neema

Independent Director : Praveen Jindal

Whole-time Director : Rinki Bankda

Company Secretary : Prachi Jain

Additional Director : Ruchi Jindal